|
FDA Finally Moves on Breast Density | Russian Hackers Escalate March 14, 2023
|
|
|
|
Together with
|
|
|
“While we all share a hallelujah! that this has finally come to pass, to quote songwriter Leonard Cohen, ‘It’s a cold and it’s a broken Hallelujah.’ But a hallelujah it is.”
|
JoAnn Pushkin, executive director of DenseBreast-info, on the FDA’s move to issue guidelines on breast density reporting.
|
|
|
After a long wait, the FDA issued a final rule that adds details on breast density reporting to the Mammography Quality Standards Act. The rule takes effect in September 2024 and should go a long way toward clarifying the issue of breast density for patients.
Breast tissue density is a risk factor for cancer, and dense breast tissue can make it more difficult for radiologists to identify tumors on conventional x-ray mammography. This shortcoming is often not communicated to women who receive “normal” mammograms, but later find out that a cancer was missed.
Prodded by a strong patient advocacy movement, individual states have been passing laws requiring women to be notified of their density status, creating a patchwork of regulation across the U.S.
The FDA in 2018 agreed to set a national standard by rolling breast density reporting into an update of the MQSA. But the long wait has frustrated many in the breast density advocacy movement.
There are several major components to the new rule, which:
- Requires breast imaging facilities to provide patients with a summary of the mammography report written in lay terms that identifies whether patients have dense or non-dense breast tissue.
- Instructs facilities to include a section in the mammography report explaining the significance of breast density.
- Establishes four categories for reporting breast tissue density in the mammography report.
- Sets the specific language to be used for reporting density.
The new rules provide much-needed national consistency in breast density reporting, and will replace the patchwork of state regulation that has developed over the years. Developers of breast density software may also benefit from the new federal rules, as they simplify the number of regulations that need to be tracked.
The Takeaway
Better late than never. While the FDA should have signed off on this years ago, now that the rules are issued the breast imaging community can move ahead with integrating them into clinical practice. The new rules should also help density reporting software developers by setting a national standard rather than a patchwork of state regulation.
|
|
|
Streamlining AI Adoption and Workflow
Check out this Blackford Analysis video detailing how its AI platform streamlines AI adoption and workflows, allowing radiology teams to achieve AI’s clinical benefits without operational sacrifices.
|
|
Building a Mobile Lung Cancer CT Screening Program
The number of patients eligible for low-dose CT lung cancer screening has expanded, and so has the need to reach at-risk patients closer to where they live. That’s why Siemens Healthineers’ Mobile Lung Screening Solution combines the quality, ease of use, and flexibility needed to create a program that meets the real-life needs of your community.
|
|
- Russian Hack Attack: A shadowy group of Russian hackers has posted to the dark web pictures of breast cancer patients who were receiving radiation therapy at a Pennsylvania hospital. The hackers are demanding ransom from Lehigh Valley Health Network, which has rejected their demands. The episode could be a sign of escalation in ransomware attacks as more hospitals refuse to pay; it also could spur more hospitals to seek safety in cloud-based data storage.
- PET/MRI Post-COVID Jab: A few patients who already had myocarditis showed heart muscle inflammation on PET/MRI after they got the COVID-19 vaccine, but for the most part post-jab complications were rare. In a study in Radiology: Cardiothoracic Imaging, researchers found that out of 54 patients, only two – who already had myocarditis symptoms – had focal FDG uptake in the heart. Researchers believe the findings show that subclinical myocardial injury is not common after COVID vaccination.
- Agfa to Launch Imaging Network: Agfa HealthCare is planning to launch the latest addition to its enterprise imaging platform, Imaging Health Network, at next month’s HIMSS 2023 conference. The solution is an aggregated community health record for medical images – providers can post data to the record, ensuring that all physicians a patient encounters will have access.
- Radiation Risks to the Heart: Low doses of radiation exposure may be a greater risk to cardiovascular health than previously thought, according to a new meta-analysis in The BMJ. Researchers reviewed 93 studies, finding that there was an excess lifetime risk of 2.3 to 3.9 cardiovascular deaths per 100 persons per exposure to 1 Gy of radiation. The findings have implications for health workers who may be frequently exposed to scatter radiation, such as in radiation therapy.
- Software Guides Density Determination: Speaking of breast density, new research presented at last week’s ECR 2023 meeting supports the role of AI-based software in analyzing breast density and steering women with dense breast tissue to mammography screening. The presentations used AI density assessment software from Volpara Health Technologies, showing that it could reduce the need for MRI screening.
- Is Radiology Ready for Gen Z? The first cohort of medical students from Generation Z will be entering radiology training this year … but is radiology ready? A new viewpoint article in AJR examines the challenges that may be posed by residents born after 1996 who grew up “fully immersed in digital technology” like the Internet and with little memory of life before smartphones. Are emojis in radiology reports next?
- Coreline Nabs FDA Nod: South Korean AI software developer Coreline Soft received FDA 510(k) clearance for its AVIEW Lung Nodule CAD software. The application assists radiologists in reviewing thoracic multislice CT exams, highlighting potential nodules that radiologists should review. The FDA action is a milestone for the company in entering the U.S. market as it prepares for an upcoming IPO.
- UCSF Radiologist Pens Novel: UCSF radiologist Dr. Olga Tymofiyeva published a science-fiction novel entitled “Just City.” The book takes place in San Francisco set in the near future and explores the ethics of a virtual reality game that enables players to inhabit different bodies and experience life from dramatically different backgrounds and circumstances.
- Delphinus Lands Third Install: Whole-breast ultrasound tomography developer Delphinus Medical Technologies has landed the third installation of its SoftVue scanner since the FDA approved it in October 2021. The University of Rochester is receiving the system, which can be used in conjunction with mammography for breast screening, in particular for women with dense breast tissue.
- CCTA AI’s CAD Advantage: A new JACC study found that Cleerly’s coronary CTA AI solution “is superior to human core lab readers” for evaluating obstructive coronary artery disease. Using CCTAs from 207 PACIFIC trial patients, the Cleerly AI-QCT solution’s stenosis grading outperformed human readers for identifying patients with ≥50% stenosis (AUCs: 0.92 vs. 0.71), and for detecting obstructive CAD on a per-vessel basis (621 vessels; AUCs: 0.88 vs. 0.77).
- Leadership Transition at Intelerad’s Insignia. There’s been a changing of the guard at Insignia Medical Systems, the UK-based provider of enterprise imaging software acquired by Intelerad Medical Systems last year. Co-founder and Managing Director Richard Dormer is retiring after 21 years and is handing the reins to Arron Edwards, also a founder of the company.
- Startup Bank Has a Startup Bank Run: As you’ve probably heard, Silicon Valley Bank collapsed last week in the largest US bank failure since 2008. SVB apparently had business relationships with half of all venture-backed technology and healthcare companies, most of which spent their weekends scrambling to recover deposits. We’ll leave the cause of the collapse to the experts, but a government intervention late Sunday addressed immediate concerns over the risk of runs on other banks and affected startups making payroll. Godspeed to everyone impacted.
|
|
Change Healthcare’s Secure Cloud
Did you know one quarter of healthcare organizations have experienced a cyber-attack in the last year? This Change Healthcare animation explains how 3rd-party certified cloud-native enterprise imaging can help secure IT infrastructure that might be exposed with re-platformed imaging systems.
|
|
5-Stages to AI Adoption
New healthcare technologies have traditionally been hard to implement, and that’s certainly been true for imaging AI, but some of AI’s challenges might have been avoided with the right standards and guidelines. Check out this Enlitic report outlining its 5-stage approach to less-challenging AI adoption.
|
|
- Because of United Imaging’s Software Upgrades for Life program, every time United Imaging launches a new solution it can automatically be installed in every compatible system at no cost.
- We hear a lot about AI’s potential to expand echocardiography to far more users and clinical settings, and a study using Us2.ai’s AI-automated echo analysis and reporting solution showed that echo’s AI-driven expansion might go far beyond what many of us had in mind.
- This European Radiology study highlighted Riverain Technologies’ ClearRead Xray – Detect as one of just two imaging AI products to achieve the FDA’s most stringent premarket approval level. See how they measured up against 99 other AI tools.
- After setting ambitious regulatory and commercialization goals, Lunit leveraged CARPL.ai’s platform and operational guidance to complete the clinical trials needed for its INSIGHT CXR and MMG AI tools’ FDA clearances.
- With burnout and staffing shortages on the rise and the increasing volume of imaging, radiology teams are searching for solutions. This interactive guide from Nuance can help you create an environment where radiologists thrive by building a powerful imaging strategy with AI-driven, real-time intelligence.
- If you’re ready to get more from your interventional suite, tune in to this Imaging Wire Show featuring Canon Medical Systems’ vascular leader Bill Newsom exploring the meaningful innovation that went into Canon’s 4D CT technology.
- MRI machines require 7,000 tons of helium every year, with per-machine helium costs of up to $39k annually – but it doesn’t have to be that way. See how the low-field Hyperfine Swoop avoids helium and infrastructure costs, while bringing MR neuroimaging into completely new clinical settings.
- Check out this patient case study showing how the Arterys Chest I MSK AI solution helped emergency physicians spot two rib fractures in a shoulder pain exam that might have gone unnoticed.
- Merative’s Merge Imaging Solutions had a big Best in KLAS 2023, winning the Cardiology and Hemodynamics categories, while scoring second-place honors in the Large PACS, Universal Viewer, and VNA categories. Merge Cardio previously scored Best in KLAS for six consecutive years, while Merge Hemo has been ranked #1 for 10 years.
- More than 70% of radiologic technologists will experience work-related stress or strain at some point in their career. GE HealthCare understands these demanding aspects of technologist workflow and has focused new X-ray system designs on ergonomics, usability, and using AI to reduce the cognitive workload for technologists and radiologists.
- Annalise.ai doubled down on its comprehensive AI strategy with the launch of its Annalise Enterprise CTB solution, which identifies 130 different non-contrast brain CT findings. Annalise Enterprise CTB analyzes brain CTs as they are acquired, prioritizes urgent cases, and provides radiologists with details on each finding (types, locations, likelihood).
- Bayer’s cloud-based Calantic Digital Solutions AI platform features a suite of disease-specific AI apps that integrate into radiologist workflows, helping radiology teams scale AI deployment and improve efficiency and quality of care.
- When Middlesex Health set out to adopt imaging AI, the Connecticut-based community hospital made the unique decision to start with non-interpretive AI solutions. See how that decision led them to Subtle Medical, and the impact it had with all of the hospital’s imaging stakeholders.
- Raising awareness about breast cancer is an important mission, but this Intelerad editorial highlights the need to match awareness with action, helped by technology to improve screening workflows.
|
|
Share The Imaging Wire
|
Spread the news & help us grow ⚡
|
Refer colleagues with your unique link and earn rewards.
|
|
|
Or copy and share your custom referral link: *|SHAREURL|*
|
You currently have *|REFERRALS|* referrals.
|
|
|
|
|